ACON Aclarion, Inc.
Healthcare · Market cap: $4.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $257.8K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $19.8K | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $62 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $50.9K | $0 |
| 2026-Q3 | $125.7K | $0 |
| 2026-Q4 | $0 | $0 |
Bought$454.3K18 buy days
Sold$00 sell days
Net insider flow+$454.3Knet buying · 5 years
Latest trade2026-08-17Williams Amanda M
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-17 | Buy | Williams Amanda M | Director | 5,857 | $2.73 | $16.0K | 1 |
| 2026-08-14 | Buy | Gould Gregory A | CFO | 10,000 | $2.45 | $24.5K | 1 |
| 2026-08-13 | Buy | Bond Ryan | Director | 21,122 | $2.37 | $50.1K | 1 |
| 2026-08-13 | Buy | Neal David K | Director | 7,500 | $2.40 | $18.0K | 1 |
| 2026-08-13 | Buy | Ness Brent | CEO | 5,234 | $2.31 | $12.1K | 1 |
| 2026-08-13 | Buy | Wesemann William | Director | 2,150 | $2.34 | $5.0K | 1 |
| 2026-05-12 | Buy | Breidbart Scott | Director | 5,664 | $3.18 | $18.0K | 1 |
| 2026-05-11 | Buy | Ness Brent | CEO | 6,289 | $3.18 | $20.0K | 1 |
| 2026-05-11 | Buy | Neal David K | Director | 2,500 | $3.10 | $7.8K | 1 |
| 2026-05-06 | Buy | Wesemann William | Director | 1,562 | $3.30 | $5.2K | 1 |
| 2025-11-26 | Buy | Ness Brent | CEO | 10 | $6.20 | $62 | 1 |
| 2022-12-29 | Buy | Lorbiecki John Paul | CFO | 22,404 | $0.45 | $10.0K | 2 |
| 2022-12-29 | Buy | Ness Brent | CEO | 16,211 | $0.54 | $8.8K | 2 |
| 2022-12-28 | Buy | Ness Brent | CEO | 2,289 | $0.42 | $961 | 1 |
| 2022-04-22 | Buy | Bond Ryan | Other C-suite | 20,000 | $2.80 | $56.0K | 1 |
| 2022-04-21 | Buy | Neal David K | Director | 34,400 | $4.35 | $149.6K | 1 |
| 2022-04-21 | Buy | Wesemann William | Director | 11,000 | $4.35 | $47.8K | 1 |
| 2022-04-21 | Buy | Ness Brent | CEO | 1,000 | $4.35 | $4.4K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Neal David K | Director | $175.4K | $0 | 2026-08-13 |
| Bond Ryan | Director | $106.1K | $0 | 2026-08-13 |
| Wesemann William | Director | $58.0K | $0 | 2026-08-13 |
| Ness Brent | CEO | $46.3K | $0 | 2026-08-13 |
| Gould Gregory A | CFO | $24.5K | $0 | 2026-08-14 |
| Breidbart Scott | Director | $18.0K | $0 | 2026-05-12 |
| Williams Amanda M | Director | $16.0K | $0 | 2026-08-17 |
| Lorbiecki John Paul | CFO | $10.0K | $0 | 2022-12-29 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-08-13 → 2026-08-17 | 6 | $125.7K | 68 | +7.1% (+0.8% raw) | -29.9% (-38.3% raw) | – | active |
| 2026-05-06 → 2026-05-12 | 4 | $50.9K | 60 | -0.7% (+1.6% raw) | -33.4% (-26.6% raw) | -48.6% (-49.4% raw) | closed |
| 2022-04-21 → 2022-04-22 | 4 | $257.8K | 39 | -26.2% (-32.9% raw) | -54.6% (-60.0% raw) | -51.8% (-60.6% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.